Search Results - "Juliusson, G"

Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry by Blimark, Cecilie Hveding, Turesson, Ingemar, Genell, Anna, Ahlberg, Lucia, Björkstrand, Bo, Carlson, Kristina, Forsberg, Karin, Juliusson, Gunnar, Linder, Olle, Mellqvist, Ulf-Henrik, Nahi, Hareth, Kristinsson, Sigurdur Y

“…Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent 'real-world' patients. The…”
Get full text

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry by Lehmann, S, Ravn, A, Carlsson, L, Antunovic, P, Deneberg, S, Möllgård, L, Rangert Derolf, Å, Stockelberg, D, Tidefelt, U, Wahlin, A, Wennström, L, Höglund, M, Juliusson, G

“…Our knowledge about acute promyelocytic leukemia (APL) patients is mainly based on data from clinical trials, whereas population-based information is scarce…”
Get full text

Recurrent mutations refine prognosis in chronic lymphocytic leukemia by Baliakas, P, Hadzidimitriou, A, Sutton, L-A, Rossi, D, Minga, E, Villamor, N, Larrayoz, M, Kminkova, J, Agathangelidis, A, Davis, Z, Tausch, E, Stalika, E, Kantorova, B, Mansouri, L, Scarfò, L, Cortese, D, Navrkalova, V, Rose-Zerilli, M J J, Smedby, K E, Juliusson, G, Anagnostopoulos, A, Makris, A M, Navarro, A, Delgado, J, Oscier, D, Belessi, C, Stilgenbauer, S, Ghia, P, Pospisilova, S, Gaidano, G, Campo, E, Strefford, J C, Stamatopoulos, K, Rosenquist, R

“…Through the European Research Initiative on chronic lymphocytic leukemia (CLL) (ERIC), we screened 3490 patients with CLL for mutations within the NOTCH1 ( n…”
Get full text

Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997–2013 by Lehmann, S, Deneberg, S, Antunovic, P, Rangert-Derolf, Å, Garelius, H, Lazarevic, V, Myhr-Eriksson, K, Möllgård, L, Uggla, B, Wahlin, A, Wennström, L, Höglund, M, Juliusson, G

Get full text

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia by Young, E, Noerenberg, D, Mansouri, L, Ljungström, V, Frick, M, Sutton, L-A, Blakemore, S J, Galan-Sousa, J, Plevova, K, Baliakas, P, Rossi, D, Clifford, R, Roos-Weil, D, Navrkalova, V, Dörken, B, Schmitt, C A, Smedby, K E, Juliusson, G, Giacopelli, B, Blachly, J S, Belessi, C, Panagiotidis, P, Chiorazzi, N, Davi, F, Langerak, A W, Oscier, D, Schuh, A, Gaidano, G, Ghia, P, Xu, W, Fan, L, Bernard, O A, Nguyen-Khac, F, Rassenti, L, Li, J, Kipps, T J, Stamatopoulos, K, Pospisilova, S, Zenz, T, Oakes, C C, Strefford, J C, Rosenquist, R, Damm, F

“…Recurrent mutations within EGR2 were recently reported in advanced-stage chronic lymphocytic leukemia (CLL) patients and associated with a worse outcome. To…”
Get full text

An open-label phase I dose-finding study of APR-246 in hematological malignancies by Deneberg, S, Cherif, H, Lazarevic, V, Andersson, P-O, von Euler, M, Juliusson, G, Lehmann, S

Get full text

On the way towards a ‘CLL prognostic index’: focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort by Cortese, D, Sutton, L-A, Cahill, N, Smedby, K E, Geisler, C, Gunnarsson, R, Juliusson, G, Mansouri, L, Rosenquist, R

Get full text

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments by Cahill, N, Bergh, A-C, Kanduri, M, Göransson-Kultima, H, Mansouri, L, Isaksson, A, Ryan, F, Smedby, K E, Juliusson, G, Sundström, C, Rosén, A, Rosenquist, R

“…In chronic lymphocytic leukemia (CLL), the microenvironment influences gene expression patterns; however, knowledge is limited regarding the extent to which…”
Get full text

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia by Mansouri, L, Cahill, N, Gunnarsson, R, Smedby, K E, Tjönnfjord, E, Hjalgrim, H, Juliusson, G, Geisler, C, Rosenquist, R

Get full text

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial by Jädersten, Martin, Lilienthal, Ingrid, Tsesmetzis, Nikolaos, Lourda, Magda, Bengtzén, Sofia, Bohlin, Anna, Arnroth, Cornelia, Erkers, Tom, Seashore‐Ludlow, Brinton, Giraud, Géraldine, Barkhordar, Giti S., Tao, Sijia, Fogelstrand, Linda, Saft, Leonie, Östling, Päivi, Schinazi, Raymond F., Kim, Baek, Schaller, Torsten, Juliusson, Gunnar, Deneberg, Stefan, Lehmann, Sören, Rassidakis, Georgios Z., Höglund, Martin, Henter, Jan‐Inge, Herold, Nikolas

“…Background Treatment of newly diagnosed acute myeloid leukaemia (AML) is based on combination chemotherapy with cytarabine (ara‐C) and anthracyclines…”
Get full text

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden by Juliusson, G, Abrahamsson, J, Lazarevic, V, Antunovic, P, Derolf, Å, Garelius, H, Lehmann, S, Myhr-Eriksson, K, Möllgård, L, Uggla, B, Wahlin, A, Wennström, L, Höglund, M

Get full text

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study by Rosso, Aldana, Juliusson, Gunnar, Lorenz, Fryderyk, Lehmann, Sören, Derolf, Åsa, Deneberg, Stefan, Jädersten, Martin, Antunovic, Petar, Cammenga, Jörg, Möllgård, Lars, Wennström, Lovisa, Ölander, Emma, Ehinger, Mats, Fogelstrand, Linda, Höglund, Martin, Lazarevic, Vladimir Lj

“…The Swedish national guidelines for treatment of acute myeloid leukemia (AML) recommend analysis of measurable residual disease (MRD) by multiparameter flow…”
Get full text

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia by GUNNARSSON, Rebeqa, MANSOURI, Larry, SMEDBY, Karin Ekström, HJALGRIM, Henrik, KARLSSON, Karin, JURLANDER, Jesper, GEISLER, Christian, JULIUSSON, Gunnar, ROSENQUIST, Richard, ISAKSSON, Anders, GÖRANSSON, Hanna, CAHILL, Nicola, JANSSON, Mattias, RASMUSSEN, Markus, LUNDIN, Jeanette, NORIN, Stefan, BUHL, Anne Mette

“…High-resolution genomic microarrays enable simultaneous detection of copy-number aberrations such as the known recurrent aberrations in chronic lymphocytic…”
Get full text

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres by Navrkalova, Veronika, Young, Emma, Baliakas, Panagiotis, Radova, Lenka, Sutton, Lesley-Ann, Plevova, Karla, Mansouri, Larry, Ljungström, Viktor, Ntoufa, Stavroula, Davis, Zadie, Juliusson, Gunnar, Smedby, Karin E, Belessi, Chrysoula, Panagiotidis, Panagiotis, Touloumenidou, Tasoula, Davi, Frederic, Langerak, Anton W, Ghia, Paolo, Strefford, Jonathan C, Oscier, David, Mayer, Jiri, Stamatopoulos, Kostas, Pospisilova, Sarka, Rosenquist, Richard, Trbusek, Martin

Get full text

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia? by Bhoi, Sujata, Baliakas, Panagiotis, Cortese, Diego, Mattsson, Mattias, Engvall, Marie, Smedby, Karin E, Juliusson, Gunnar, Sutton, Lesley-Ann, Mansouri, Larry

Get full text

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients by Gunnarsson, R, Isaksson, A, Mansouri, M, Göransson, H, Jansson, M, Cahill, N, Rasmussen, M, Staaf, J, Lundin, J, Norin, S, Buhl, A M, Smedby, K E, Hjalgrim, H, Karlsson, K, Jurlander, J, Juliusson, G, Rosenquist, R

Get full text

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk by Sava, G P, Speedy, H E, Di Bernardo, M C, Dyer, M J S, Holroyd, A, Sunter, N J, Marr, H, Mansouri, L, Deaglio, S, Karabon, L, Frydecka, I, Jamroziak, K, Woszczyk, D, Juliusson, G, Smedby, K E, Jayne, S, Majid, A, Wang, Y, Dearden, C, Hall, A G, Mainou-Fowler, T, Jackson, G H, Summerfield, G, Harris, R J, Pettitt, A R, Allsup, D J, Bailey, J R, Pratt, G, Pepper, C, Fegan, C, Rosenquist, R, Catovsky, D, Allan, J M, Houlston, R S

Get full text

Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation by Frödin, U., Lotfi, K., Fomichov, V., Juliusson, G., Börjeson, S.

“…Health‐related quality of life (HRQL) was evaluated in 94 patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) after myeloablative…”
Get full text

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors by MARINCEVIC, Millaray, MANSOURI, Mahmoud, ROSENQUIST, Richard, KANDURI, Meena, ISAKSSON, Anders, GÖRANSSON, Hanna, SMEDBY, Karin Ekström, JURLANDER, Jesper, JULIUSSON, Gunnar, DAVI, Fred, STAMATOPOULOS, Kostas

“…Numerous subsets of patients with chronic lymphocytic leukemia display similar immunoglobulin gene usage with almost identical complementarity determining…”
Get full text

Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma by Juliusson, Gunnar, Celsing, Fredrik, Turesson, Ingemar, Lenhoff, Stig, Adriansson, Magnus, Malm, Claes

“…Twenty‐three patients with advanced and heavily pretreated myeloma were treated with thalidomide. Starting dose was 200 mg/d, and 20 patients had dose…”
Get full text